New hope for Tough-to-Treat blood cancers: experimental pill shows promise
NCT ID NCT04756726
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 30 times
Summary
This early-stage study is testing an experimental oral drug called CFT7455 in about 224 adults with non-Hodgkin's lymphoma or multiple myeloma that has returned or stopped responding to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Some participants with multiple myeloma may also receive the drug combined with dexamethasone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Colorado Blood Cancer Institute (Sarah Cannon Research Institute)
Denver, Colorado, 80218, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Phoenix, Arizona, 85054, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Mt Sinai Medical Center
New York, New York, 10029, United States
-
Tennessee Oncology (Sarah Cannon Research Institute)
Nashville, Tennessee, 37203, United States
-
University of California-San Francisco
San Francisco, California, 94143, United States
-
Washington University School of St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.